First Drug to Delay Type 1 Diabetes Approved by FDAThe treatment held off disease onset by an average of two years in a clinical trial, but it won’t be cheapLast week, the Food and Drug Administration approved the first drug to delay the onset of Type 1 diabetes.In a clinical trial of 76 participants at a high risk of diabetes, those who received the treatment were diagnosed an average of four years after the trial, compared to two years for those who received a placebo, according to NBC News’ Berkeley Lovelace Jr.The FDA approved the treatment for people ages 8 and older at a high risk of developing Type 1 diabetes, according to Medscape Medical News’ Miriam E. Tucker.The drug’s label also includes a warning for cytokine release syndrome, an overly aggressive immune response to treatment.To help with payment, one of the companies making the drug, Provention Bio, will offer a patient assistance program, a spokesperson told NBC News via email."